Literature DB >> 10628995

Cellular Werner phenotypes in mice expressing a putative dominant-negative human WRN gene.

L Wang1, C E Ogburn, C B Ware, W C Ladiges, H Youssoufian, G M Martin, J Oshima.   

Abstract

Mutations at the Werner helicase locus (WRN) are responsible for the Werner syndrome (WS). WS patients prematurely develop an aged appearance and various age-related disorders. We have generated transgenic mice expressing human WRN with a putative dominant-negative mutation (K577M-WRN). Primary tail fibroblast cultures from K577M-WRN mice showed three characteristics of WS cells: hypersensitivity to 4-nitroquinoline-1-oxide (4NQO), reduced replicative potential, and reduced expression of the endogenous WRN protein. These data suggest that K577M-WRN mice may provide a novel mouse model for the WS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10628995      PMCID: PMC1460888     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  24 in total

Review 1.  WRN mutations in Werner syndrome.

Authors:  M J Moser; J Oshima; R J Monnat
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

2.  The Bloom's syndrome gene product is homologous to RecQ helicases.

Authors:  N A Ellis; J Groden; T Z Ye; J Straughen; D J Lennon; S Ciocci; M Proytcheva; J German
Journal:  Cell       Date:  1995-11-17       Impact factor: 41.582

3.  Positional cloning of the Werner's syndrome gene.

Authors:  C E Yu; J Oshima; Y H Fu; E M Wijsman; F Hisama; R Alisch; S Matthews; J Nakura; T Miki; S Ouais; G M Martin; J Mulligan; G D Schellenberg
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

4.  Growth characteristics of Werner syndrome cells in vitro.

Authors:  D Salk; E Bryant; H Hoehn; P Johnston; G M Martin
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

5.  Cytogenetic aspects of Werner syndrome.

Authors:  D Salk; K Au; H Hoehn; G M Martin
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

6.  Cloning and characterization of RECQL, a potential human homologue of the Escherichia coli DNA helicase RecQ.

Authors:  K L Puranam; P J Blackshear
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

7.  Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype.

Authors:  G M Martin; C A Sprague; C J Epstein
Journal:  Lab Invest       Date:  1970-07       Impact factor: 5.662

8.  Colony size distributions as a measure of in vivo and in vitro aging.

Authors:  J R Smith; O M Pereira-Smith; E L Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

9.  Spontaneous and induced chromosomal instability in Werner syndrome.

Authors:  E Gebhart; R Bauer; U Raub; M Schinzel; K W Ruprecht; J B Jonas
Journal:  Hum Genet       Date:  1988-10       Impact factor: 4.132

10.  The expression of proliferation-dependent antigens during the lifespan of normal and progeroid human fibroblasts in culture.

Authors:  I R Kill; R G Faragher; K Lawrence; S Shall
Journal:  J Cell Sci       Date:  1994-02       Impact factor: 5.285

View more
  16 in total

1.  Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein.

Authors:  Yongli Bai; John P Murnane
Journal:  Hum Genet       Date:  2003-06-25       Impact factor: 4.132

Review 2.  Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair.

Authors:  J J P Perry; L Fan; J A Tainer
Journal:  Neuroscience       Date:  2006-12-15       Impact factor: 3.590

3.  Genetic Manipulation of Homologous Recombination In Vivo Attenuates Intestinal Tumorigenesis.

Authors:  Michael A McIlhatton; Kevin Murnan; Daniel Carson; Gregory P Boivin; Carlo M Croce; Joanna Groden
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-23

Review 4.  Helicase-inactivating mutations as a basis for dominant negative phenotypes.

Authors:  Yuliang Wu; Robert M Brosh
Journal:  Cell Cycle       Date:  2010-10-15       Impact factor: 4.534

Review 5.  WRN Mutation Update: Mutation Spectrum, Patient Registries, and Translational Prospects.

Authors:  Koutaro Yokote; Sirisak Chanprasert; Lin Lee; Katharina Eirich; Minoru Takemoto; Aki Watanabe; Naoko Koizumi; Davor Lessel; Takayasu Mori; Fuki M Hisama; Paula D Ladd; Brad Angle; Hagit Baris; Kivanc Cefle; Sukru Palanduz; Sukru Ozturk; Antoinette Chateau; Kentaro Deguchi; T K M Easwar; Antonio Federico; Amy Fox; Theresa A Grebe; Beverly Hay; Sheela Nampoothiri; Karen Seiter; Elizabeth Streeten; Raul E Piña-Aguilar; Gemma Poke; Martin Poot; Renata Posmyk; George M Martin; Christian Kubisch; Detlev Schindler; Junko Oshima
Journal:  Hum Mutat       Date:  2016-10-07       Impact factor: 4.878

6.  Functional deficit associated with a missense Werner syndrome mutation.

Authors:  Takashi Tadokoro; Ivana Rybanska-Spaeder; Tomasz Kulikowicz; Lale Dawut; Junko Oshima; Deborah L Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2013-04-11

7.  Shortcomings of short hairpin RNA-based transgenic RNA interference in mouse oocytes.

Authors:  Lenka Sarnova; Radek Malik; Radislav Sedlacek; Petr Svoboda
Journal:  J Negat Results Biomed       Date:  2010-10-12

8.  Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase.

Authors:  Kiranjit K Dhillon; Julia M Sidorova; Tina M Albertson; Judith B Anderson; Warren C Ladiges; Peter S Rabinovitch; Bradley D Preston; Raymond J Monnat
Journal:  DNA Repair (Amst)       Date:  2009-11-05

9.  RecQ DNA helicase HRDC domains are critical determinants in Neisseria gonorrhoeae pilin antigenic variation and DNA repair.

Authors:  Michael P Killoran; Petra L Kohler; Joseph P Dillard; James L Keck
Journal:  Mol Microbiol       Date:  2008-11-11       Impact factor: 3.501

Review 10.  From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.

Authors:  L S Cox; R G A Faragher
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.